With an FDA decision looming over its first foray into the acute pain space, Vertex Pharmaceuticals has commissioned a pair of surveys to take stock of that space. The resulting report ...

Vertex (VERX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

You might have seen Cialis® — the erectile dysfunction (ED) drug — available in doses ranging from 2.5 mg to 20 mg. Surely, ...

Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. Key Insights Using the 2 Stage Free Cash Flow ...

Vertex Pharmaceuticals’ breakthrough in cystic fibrosis was a medicine that treats just 4% of patients who have the lung disorder. Today, Vertex’s portfolio of blockbuster CF products spans ...

15 analysts have expressed a variety of opinions on Vertex Pharmaceuticals VRTX over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The vertex shader is used to transform the attributes of vertices (points of a triangle) such as color, texture, position and direction from the original color space to the display space.

M.D. Ph.D., 50 Northern Ave, Boston, Massachusetts 02210, Chief Scientific Officer, Executive Vice President, Global Research Vertex Pharmaceuticals Incorporated ...

Sept 24 (Reuters) - Vertex Energy (VTNR.O), opens new tab has filed for bankruptcy in a Texas court, just months after it paused renewable diesel output at an Alabama refinery over macroeconomic ...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...